Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
5.41
-0.17 (-3.05%)
Dec 5, 2025, 11:11 AM EST - Market open
IMDX Market Cap
IMDX has a market cap or net worth of $155.07 million as of December 5, 2025. Its market cap has increased by 253.25% in one year.
Market Cap
155.07M
Enterprise Value
144.38M
1-Year Change
253.25%
Ranking
Category
Stock Price
$5.41
Market Cap Chart
Since January 4, 2016, IMDX's market cap has decreased from $228.70M to $155.07M, a decrease of -32.19%. That is a compound annual growth rate of -3.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 153.10M | 281.80% |
| Dec 31, 2024 | 40.10M | 93.72% |
| Dec 29, 2023 | 20.70M | -45.67% |
| Dec 30, 2022 | 38.10M | -80.96% |
| Dec 31, 2021 | 200.10M | 24.52% |
| Dec 31, 2020 | 160.70M | 37.47% |
| Dec 31, 2019 | 116.90M | 108.38% |
| Dec 31, 2018 | 56.10M | -61.60% |
| Dec 29, 2017 | 146.10M | -27.82% |
| Dec 30, 2016 | 202.40M | -11.50% |
| Jan 4, 2016 | 228.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.46B |
| Johnson & Johnson | 494.75B |
| AbbVie | 397.64B |
| UnitedHealth Group | 294.18B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.90B |
| Abbott Laboratories | 219.64B |